Clip Health was one of over 700 exhibitors at this year’s American Association of Clinical Chemistry (AACC) Annual Scientific Meeting held in Chicago at the McCormick Place Convention Center on July 24 – 28, demonstrating the fastest rapid antigen test on the market. Their newest COVID-19 test was submitted to the U.S. Food and Drug…
Small companies that won big testing contracts earlier in the pandemic are now seeing COVID-19 testing shift to the home. Next to big-name brands like Abbott Laboratories and Becton Dickinson, a swath of lesser-known companies are selling COVID-19 tests to schools, hospitals and corporations. Buoyed by the pandemic, these small firms and startups have seen…
New additions include Vice President appointments for Assay & Product Development, Quality & Regulatory Fremont, Calif – May 30, 2022 – Clip Health, a pioneer in the development of accessible and accurate diagnostics, has made two skilled additions to its leadership team. To continue innovating towards the Company’s product vision of diagnostics-enabled “full stack” healthcare,…
Clip Health joined more than 500 distributors at NDC Exhibition 2022, April 11-12, at the Gaylord Opryland Resort & Convention Center in Nashville, where the company showcased its smartphone-based COVID-19 antigen test, as well as a preview of the new Clip Core Analyzer, which will launch in June of 2021. Clip Health’s COVID-19 antigen test…
Are you ready to be compliant for the February deadline? Learn how to navigate federally-mandated testing and vaccination requirements for your business. Join us Thursday, January 13th at 10AM PST for a 30-minute webinar and Q&A providing information about OSHA’s ETS requirements, Clip Health’s compliance solutions, testing programs and immunization management. Limited to 50 attendees,…
Clip Health™, a fast-growing healthtech company and diagnostics innovator, today announced its DBA name change and company rebrand from its corporate name Luminostics, Inc.
Luminostics announced the receipt of emergency use authorization (EUA) from the Food and Drug Administration (FDA) and production scale-up activities for their Clip COVID Rapid Antigen Test.
Luminostics has been awarded a contract by the National Institutes of Health (in collaboration with the Biomedical Advanced Research and Development Authority) under the Rapid Acceleration of Diagnostics Tech (RADx Tech) fast track program, which supports innovative technologies to increase the U.S. testing capacity for SARS-CoV-2.
A University of Florida professor and his industry collaborators have won second place in a technology competition sponsored by the National Institutes of Health for a smartphone-based, rapid saliva test they developed that can be used to diagnose COVID-19, along with two other diseases of major global importance, malaria and anemia. A team consisting of…
Luminostics’ technology and product vision were profiled in an article by Leo O’Connor for 360Dx, a diagnostics industry publication by GenomeWeb, in December 2019. Reach out to us for access to the full-length article.